WebCyclophosphamide, also called Cytoxan, is classified as a “cytotoxic agent”, because it has a toxic effect on many types of cells (“good” cells as well as “bad”). Cyclophosphamide … WebJul 1, 2016 · Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab is the standard therapy for physically fit patients with advanced chronic lymphocytic leukaemia. This international phase 3 study compared the efficacy and tolerance of the standard therapy with a potentially less toxic combination consisting of bendamustine and …

Rituximab for the Treatment of Relapses in ANCA-associated …

WebNational Center for Biotechnology Information WebConclusions: Our data show that sequential therapy with cyclophosphamide and rituximab, upon a major relapse, in patients with frequently relapsing AAV, is associated with prolonged remission, allowing minimization of the ultimate exposure to cyclophosphamide. MeSH terms Adolescent Adult Aged crystal motional parameters

Landmark Trials on the use of Rituximab in ANCA Associated Vasculitis

WebTreatment with rituximab has led to remission rates of 80 to 90% among patients with refractory ANCA-associated vasculitis and may be safer than cyclophosphamide regimens. Methods We compared... WebRemission induction for active nonsevere disease for GPA and MPA Remission maintenance for GPA and MPA Treatment of disease relapse for GPA and MPA Treatment of refractory disease for GPA and MPA Treatment of sinonasal, airway, and mass lesions for GPA and MPA Other considerations for GPA and MPA Recommendations and … WebSep 22, 2024 · The chemotherapy drugs that are given before the T-Cell therapy are cyclophosphamide, fludarabine and rituximab. Rituximab is an immunotherapy drug. These chemotherapy drugs will reduce the number of normal (unaltered) T-Cells in the body to make room for the altered T-cells to kill the cancer cells. crystalmotors parabrezza